1. Allosteric Inhibition of a Mammalian Lectin
- Author
-
Felix F. Fuchsberger, Jonas Aretz, Nandor Ziebart, Hengxi Zhang, Narges Molavi, Marc Nazaré, Christoph Rademacher, and Upendra Rao Anumala
- Subjects
Langerin ,Protein family ,Allosteric regulation ,Druggability ,010402 general chemistry ,01 natural sciences ,Biochemistry ,Catalysis ,Mice ,Structure-Activity Relationship ,Colloid and Surface Chemistry ,Structure–activity relationship ,Animals ,Lectins, C-Type ,Receptor ,biology ,Molecular Structure ,010405 organic chemistry ,Chemistry ,Lectin ,General Chemistry ,Surface Plasmon Resonance ,0104 chemical sciences ,3. Good health ,Mannose-Binding Lectins ,Pyrimidines ,Antigens, Surface ,biology.protein ,Heteronuclear single quantum coherence spectroscopy ,Allosteric Site - Abstract
Glycan-binding proteins are key components of central physiological and cellular processes such as self-/non-self-recognition, cellular tissue homing, and protein homeostasis. Herein, C-type lectins are a diverse protein family that play important roles in the immune system, rendering them attractive drug targets. To evaluate C-type lectin receptors as target proteins for small-molecule effectors, chemical probes are required, which are, however, still lacking. To overcome the supposedly poor druggability of C-type lectin receptors and to identify starting points for chemical probe development, we screened murine langerin using 1H and 19F NMR against a library of 871 drug-like fragments. Subsequently, hits were validated by surface plasmon resonance and enzyme-linked lectin assay. Using structure–activity relationship studies and chemical synthesis, we identified thiazolopyrimidine derivatives with double-digit micromolar activity that displayed langerin selectivity. Based on 1H–15N HSQC NMR and competiti...
- Published
- 2018